KCNK7 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNK7 Gene</th>
</tr>
<tr>
<td class="label">HGNC symbol</td>
<td>KCNK7</td>
</tr>
<tr>
<td class="label">Full name</td>
<td>Potassium two pore domain channel subfamily K member 7</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>10091</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000184058</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O43167</td>
</tr>
<tr>
<td class="label">Cytogenetic location</td>
<td>11q13.1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
KCNK7 encodes potassium two-pore-domain channel subfamily K member 7 (K2P7), a member of the leak/background potassium channel superfamily that helps set resting membrane potential and excitability thresholds in [neurons](/entities/neurons).[@goldstein2005][@enyedi2010] Although KCNK7 is less experimentally resolved than channels such as KCNK2 (TREK1) or KCNK3 (TASK1), its predicted architecture and expression profile place it within core ion-homeostasis pathways relevant to neuronal vulnerability in neurodegeneration.[@goldstein2005][@feliciangeli2015]
The biological rationale for tracking KCNK7 in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/amyotrophic-lateral-sclerosis) is mechanistic rather than monogenic: small shifts in background potassium conductance can alter firing stability, calcium loading, and metabolic demand, all of which interact with [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction), [excitotoxicity](/mechanisms/excitotoxicity), and [neuroinflammation](/mechanisms/neuroinflammation).[@enyedi2010][@styr2018][@martin2010]
Gene and Protein Architecture
Canonical gene attributes
KCNK7 belongs to the K2P channel family, which is structurally defined by four transmembrane helices and two pore-forming domains per subunit; functional channels are assembled as dimers.[@goldstein2005][@enyedi2010] This architecture supports constitutive or weakly gated K+ flux, creating the "leak" conductance that stabilizes membrane voltage around subthreshold ranges.[@enyedi2010][@feliciangeli2015]
Biophysical relevance of K2P channels
K2P channels are not simple passive pores. Many integrate pH, stretch, temperature, lipids, and neuromodulators to tune excitability over long timescales.[@enyedi2010][@feliciangeli2015] Even when KCNK7-specific electrophysiology is sparse, family-level principles justify disease relevance: reductions in leak conductance increase membrane resistance and can amplify depolarizing inputs, while excess conductance can suppress adaptive firing and network responsiveness.[@enyedi2010][@styr2018]
Expression and Circuit Context
Transcript resources and curated channel atlases indicate KCNK7 expression in nervous-system tissues with additional peripheral expression.[@goldstein2005][@fagerberg2014] In systems terms, background K+ channels most strongly influence:
Spike-threshold stability.
Rebound excitability after inhibitory inputs.
Synchronization risk in recurrent networks.
Energetic burden from sustained high-frequency firing.[@enyedi2010][@styr2018]These functions are especially relevant in regions already vulnerable to proteostasis and mitochondrial stress, including cortical and basal-ganglia circuits implicated across AD/PD spectrum disorders.[@styr2018][@martin2010]
Mechanistic Relevance to Neurodegeneration
1) Excitability stress and calcium burden
When background K+ buffering is reduced, neurons spend more time near depolarized states, increasing calcium entry via voltage-dependent pathways and potentiating excitotoxic cascades.[@styr2018][@parsons2014] This creates feed-forward interactions with synaptic glutamatergic stress and oxidative injury, established mechanisms across major neurodegenerative diseases.[@styr2018][@martin2010][@parsons2014]
2) Coupling to mitochondrial fragility
Hyperexcitability raises ATP demand and [ROS](/entities/reactive-oxygen-species) production. In neurons with pre-existing mitochondrial compromise, even modest ion-channel dysregulation can lower resilience and accelerate degeneration.[@martin2010][@mattson2008] KCNK7 should therefore be interpreted as a potential modifier of energy-stress thresholds rather than a standalone causal lesion.
3) Neuroinflammatory amplification
Cytokine-rich microenvironments alter ion-channel expression and membrane properties, while abnormal excitability can further promote inflammatory signaling and synaptic dysfunction.[@martin2010][@heneka2014] This bidirectional loop makes leak-channel biology relevant to disease progression models, especially where glial activation is persistent.
Genetics and Disease Associations
At present, KCNK7 is not among the strongest repeatedly replicated Mendelian drivers of AD/PD/ALS. However, two clinically meaningful categories remain:
Modifier hypotheses: common or rare variants may influence progression rate, symptom domains, or treatment response rather than disease incidence.
Network convergence: KCNK7 may act in polygenic excitability modules together with other K+, HCN, and Ca2+ channel genes.[@styr2018][@frere2018]This is consistent with broader ion-channel literature, where distributed small effects can still materially shape circuit stability in chronic neurodegeneration.
Translational and Therapeutic Implications
Direct KCNK7-selective drugs are not yet in routine clinical use. Near-term translational strategies are therefore pathway-level:
- Prioritize channel-module biomarkers (EEG signatures, excitability phenotypes) rather than single-gene readouts.[@styr2018][@frere2018]
- Explore whether existing ion-channel modulators normalize phenotypes in KCNK7-enriched circuits.[@enyedi2010][@feliciangeli2015]
- Combine excitability-targeted approaches with mitochondrial and anti-inflammatory interventions in stage-specific protocols.[@martin2010][@mattson2008]
For trial design, KCNK7 is best positioned as a stratification variable or mechanistic covariate in broader electrophysiology-informed studies.
Research Priorities
Patch-clamp characterization of human KCNK7 in standardized heterologous systems.
Cell-type-resolved human brain expression maps in AD/PD/ALS tissue.
Variant-to-function assays to separate benign diversity from excitability-relevant effects.
Integration with network biomarkers to identify clinically meaningful subgroups.See Also
- [KCNK7 Protein (KCNK Potassium Channel 7)](/proteins/kcnk7-protein)
- [HCN3 Gene](/genes/hcn3)
- [Excitotoxicity](/mechanisms/excitotoxicity)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Neuroinflammation](/mechanisms/neuroinflammation)
External Links
- [NCBI Gene: KCNK7](https://www.ncbi.nlm.nih.gov/gene/10091)
- [UniProt: O43167](https://www.uniprot.org/uniprot/O43167)
- [Ensembl: ENSG00000184058](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184058)
References
[Goldstein SAN, Bockenhauer D, O'Kelly I, Zilberberg N, Potassium leak channels and the KCNK family of two-P-domain subunits (2005)](https://pubmed.ncbi.nlm.nih.gov/15797363/)
[Enyedi P, Czirjak G, Molecular background of leak K+ currents: two-pore domain potassium channels (2010)](https://pubmed.ncbi.nlm.nih.gov/19861953/)
[Feliciangeli S, Chatelain FC, Bichet D, Lesage F, The family of K2P channels: salient structural and functional properties (2015)](https://pubmed.ncbi.nlm.nih.gov/25857729/)
[Styr B, Slutsky I, Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/27477310/)
[Martin LJ, Mitochondrial and cell death mechanisms in neurodegenerative diseases (2010)](https://pubmed.ncbi.nlm.nih.gov/18724929/)
[Fagerberg L, Hallstrom BM, Oksvold P, et al, Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics (2014)](https://pubmed.ncbi.nlm.nih.gov/24309898/)
[Parsons MP, Raymond LA, Extrasynaptic NMDA receptor involvement in central nervous system disorders (2014)](https://pubmed.ncbi.nlm.nih.gov/23986242/)
[Mattson MP, Gleichmann M, Cheng A, Mitochondria in neuroplasticity and neurological disorders (2008)](https://pubmed.ncbi.nlm.nih.gov/21530562/)
[Heneka MT, Kummer MP, Latz E, Innate immune activation in neurodegenerative disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25083192/)
[Frere S, Slutsky I, Alzheimer's disease: from firing instability to homeostasis network collapse (2018)](https://pubmed.ncbi.nlm.nih.gov/30097519/)